(Q45140920)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21527891%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

title

Blood pressure and heart rate effects, weight loss and maintenance during long-term phentermine pharmacotherapy for obesity (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21527891%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

0 references

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21527891%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

2

Frank L Greenway

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21527891%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

author name string

Ed J Hendricks

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21527891%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

Eric C Westman

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21527891%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

publication date

28 April 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21527891%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21527891%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

volume

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21527891%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21527891%20AND%20SRC:MED&resulttype=core&format=json

30 January 2020

page(s)

2351-2360

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21527891%20AND%20SRC:MED&resulttype=core&format=json

National trends in antiobesity medication use.

30 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2011.94

How physician obesity specialists use drugs to treat obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2011.94

Pharmacologic therapies for obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2011.94

Lifestyle and pharmacological approaches to weight loss: efficacy and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2011.94

21 January 2018

Safety of obesity drugs

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2011.94

Obesity in childhood. A controlled trial of anorectic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2011.94

Effects on weight reduction and safety of short-term phentermine administration in Korean obese people

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2011.94

The long-term management of obesity with continuing pharmacotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2011.94

Weight and metabolic outcomes after 2 years on a low-carbohydrate versus low-fat diet: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2011.94

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2011.94

Effects of weight loss in overweight/obese individuals and long-term lipid outcomes--a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2011.94

Body mass index and the prevalence of hypertension and dyslipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2011.94

Long-term weight loss from lifestyle intervention benefits blood pressure?: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2011.94

Hierarchical analysis of anthropometric indices in the prediction of 5-year incidence of hypertension in apparently healthy adults: the ATTICA study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2011.94

Cardiovascular and metabolic predictors of progression of prehypertension into hypertension: the Strong Heart Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2011.94

Prehypertension among middle-aged and elderly people in Taiwan: a five-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2011.94

Weight loss and reduction of blood pressure and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2011.94

Acute physiological and behavioral effects of intranasal methamphetamine in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2011.94

Physiological and subjective responses to controlled oral 3,4-methylenedioxymethamphetamine administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2011.94

Cardiovascular effects of longer-term, high-dose OROS methylphenidate in adolescents with attention deficit hyperactivity disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2011.94

A double-blind clinical trial in weight control. Use of fenfluramine and phentermine alone and in combination

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2011.94

Long-term weight control study. I (weeks 0 to 34). The enhancement of behavior modification, caloric restriction, and exercise by fenfluramine plus phentermine versus placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2011.94

Enhanced weight loss following coadministration of pramlintide with sibutramine or phentermine in a multicenter trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2011.94

Treatment of obesity with "combination" pharmacotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2011.94

Lorcaserin--not a new weapon in the battle with appetite

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2011.94

Association between adult attention deficit/hyperactivity disorder and obesity in the US population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2011.94

Effectiveness of Medifast supplements combined with obesity pharmacotherapy: a clinical program evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2011.94

Long-term drug treatment of obesity in a private practice setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2011.94